Posts
May 11 2012
Douglas S. Ellenoff, a member of the Firm, spoke at New York's first Crowdfunding 101 Workshop. He spoke about the firm's role in the process that generated the JOBS Act, our current activity in assisting with the SEC's rule-making process and the current & future legal issues that will effect crowdfunding platforms planning to present equity-based crowdfunding solutions for small businesses.
May 01 2012
University General Health Systems, Inc. announced the closing of their Registered Direct offering in the amount of $3,100,000. EG&S acted as counsel to the Investor.
April 25 2012
Oculus Innovative Sciences, Inc. announced the closing of their Registered Direct offering in the amount of $3,124,000. EG&S acted as counsel to the placement agent.
April 20 2012
Douglas S. Ellenoff, a member of the Firm, attended meetings between several department heads of the SEC and the crowdfunding industry, including the The National Crowdfunding Association (NLCFA).
April 19 2012
Ellenoff Grossman & Schole LLP was the premier sponsor at Deal Flow Media's CrowdFunding Conference, in New York City. Douglas S. Ellenoff, a member of the Firm, opened the conference with his keynote address focusing on the outlook of the CrowdFunding Market. Sarah E. Williams, also a member of the Firm, moderated the panel: Understanding Policy Issues vs. Securities Rules if you're in the CrowdFunding Business.
April 18 2012
Titan Pharmaceuticals,Inc. announced the closing of their Registered Direct offering in the amount of $5,540,000. EG&S acted as counsel to the placement agent.
April 18 2012
ParkerVision announced the closing of their Registered Direct in the amount of $1,963,501. EG&S acted as counsel to the placement agent.
April 11 2012
Dipexium Pharmaceuticals, LLC, a private biotechnology company, closed a venture private placement of Series A membership interests and warrants in an amount of over $500,000. EG&S acted as counsel to Dipexium.